Amid shifting politics, can we build stable global health systems?
Virologist, policymaker, diplomat: Dr. John Nkengasong discusses the current Ebola outbreak, and how public health is inherently political.
How does the gut-brain connection work?
Two experts at the forefront of untangling the gut-brain connection explain its role in IBS, Parkinson’s, and depression.
Promising new treatments for pancreatic cancer and ALS
A new pancreatic cancer drug doubles survival times. And a new treatment for a rare form of ALS slows and improves some patients’ symptoms.
FDA approves a well-known sunscreen ingredient—finally
The FDA approved the first new sunscreen ingredient in over 20 years—one that’s long been used around the world. What took so long?
Why can I handle tequila but not rum?
Do sugary drinks really cause more intense hangovers? Is wine both bad for you and good for you? Experts take on the chemistry of happy hour.
How extreme athletes like Alex Honnold keep their cool
Everyone has stressful moments. But for some athletes, keeping calm can be the difference between life and death.
17:37
Scientists retire ‘implausible’ worst-case climate scenario
Scientists say one extreme climate change scenario isn’t realistic. Plus, a journalist’s quest to discover new insect species in New York.
How the US patent system keeps drug prices high
Pharmaceutical companies can use overlapping patents to extend their exclusive rights to a drug, delaying production of cheaper generic forms.
A virus hunter in Nigeria has thoughts on the Ebola outbreak
A Nigeria-based molecular biologist breaks down the current Ebola outbreak, and what’s needed to improve disease monitoring across Africa.
How the financial industry has curbed drug development
“Pharma Monopoly” shows how the financial industry’s influence over pharmaceutical decision-making means fewer new drugs and higher prices.